Qube Research & Technologies Ltd

Position in GERN — Geron Corp

CIK 1729829 LONDON, X0

Position in GERN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,302,827

+$2,148,498 QoQ

Shares Held

3,361,584

+132.5% QoQ

Ownership

0.523%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#31

of 259 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. GERN ranks #82 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,302,827	3,361,584	+132.5%	Shares	Sole	2026-08-14
2026-03-31	$2,154,329	1,445,859	-53.5%	Shares	Sole	2026-05-15
2025-12-31	$4,101,938	3,107,529	-34.2%	Shares	Sole	2026-02-17
2025-09-30	$6,470,260	4,722,818	-5.2%	Shares	Sole	2025-11-14
2025-06-30	$7,024,053	4,981,598	+3.9%	Shares	Sole	2025-08-14
2025-03-31	$7,624,932	4,795,555	+213.6%	Shares	Sole	2025-05-15
2024-12-31	$5,413,714	1,529,298	+307.4%	Shares	Sole	2025-02-14
2024-06-30	$1,591,674	375,395	-19.6%	Shares	Sole	2024-08-14
2023-12-31	$984,682	466,674	+1134.4%	Shares	Sole	2024-02-13
2023-06-30	$121,354	37,805	-69.9%	Shares	Sole	2023-08-14
2023-03-31	$272,584	125,615	-56.5%	Shares	Sole	2023-05-15
2022-09-30	$675,167	288,533	+379.9%	Shares	Sole	2022-11-14
2020-12-31	$95,593	60,122	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.